...入方案如何，分叉病变 (bifurcation lesions) 患者接受 CYPHER(R) 西罗莫司洗脱冠状动脉支架 (Sirolimus-eluting Coronary Stent) 治疗六个月的严重事件发生率低。分叉病变是指在血管分叉处向两部分血管蔓延的病变，通常难以治疗。
基于12个网页-相关网页
昨日一个热点会议发布，新的研究数据表明与药物洗脱支架(DES)有关的急性冠状动脉综合征死亡率不断增加。
NEW DATA showing increased mortality rates associated with drug eluting stents (DES) in acute coronary syndromes were presented in a Hot Line Session yesterday.
目的：探讨ST段抬高性心肌梗死患者经皮冠状动脉介入置入雷帕霉素药物洗脱支架内血栓形成的相关因素及预后。
Objective to study the related factors and prognosis of rapamycin drug-eluting stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
结论雷帕霉素洗脱支架术治疗多支冠状动脉病变患者长期疗效与CABG相当，是治疗多支病变冠心病患者一种较好的方法。
Conclusion a better treatment for the patients with multi-vessel coronary disease, rapamycin-eluting stent implantation has the clinical effects comparable to those of the CABG.
应用推荐